Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 30, 2021
Associations of corin genetic polymorphisms with salt sensitivity, blood pressure changes, and hypertension incidence in Chinese adultsTing Zou, Shi Yao, Ming-Fei Du, et al.
Frontiers in Cardiovascular Medicine|December 6, 2021
Associations of Serum Uromodulin and Its Genetic Variants With Blood Pressure and Hypertension in Chinese AdultsYang Wang, Ming-Fei Du, Shi Yao, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Associations of Renalase With Blood Pressure and Hypertension in Chinese AdultsYang Wang, Chen Chen, Gui-Lin Hu, et al.
Eclinicalmedicine|May 6, 2022
Early life body mass index trajectories and albuminuria in midlife: A 30-year prospective cohort studyYang Wang, Fei Li, Chao Chu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 30, 2022
Associations of genetic variations in NEDD4L with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adultsZe-Jiaxin Niu, Shi Yao, Xi Zhang, et al.
Journal of Hypertension|March 30, 2021
Associations of plasma PAPP-A2 and genetic variations with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adultsYang Wang, Hao Jia, Wei-Hua Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)Michael K Wong, Mohammed M Milhem, Joseph J Sacco, et al.
Hypertension (Dallas, Tex. : 1979)|April 1, 2022
Associations of Long-Term Visit-to-Visit Blood Pressure Variability With Subclinical Kidney Damage and Albuminuria in Adulthood: a 30-Year Prospective Cohort StudyYang Wang, Peng Zhao, Chao Chu, et al.
The New England Journal of Medicine|June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaMichael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Cancer Discovery|April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET RearrangementsSeshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.
Pageof 7